# Second Primary Cancers in Patients With Castration Resistant Prostate Cancer

> **NCT02702908** · — · COMPLETED · sponsor: **Bayer** · enrollment: 6442 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **OTHER:** 

## Key facts

- **NCT ID:** NCT02702908
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-15
- **Primary completion:** 2017-10-20
- **Final completion:** 2017-10-20
- **Target enrollment:** 6442 (ACTUAL)
- **Last updated:** 2018-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702908, "Second Primary Cancers in Patients With Castration Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02702908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*